Synergistic upregulation of PD‑L1 in tumor cells and CD39 in tumor‑infiltrating CD8+ T cells leads to poor prognosis in patients with hepatocellular carcinoma
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.High programmed cell death ligand 1 (PD-L1) on tumor cells and CD39 on T cells in hepatocellular carcinoma (HCC) patients indicates poor prognosis. This combination suggests immune escape and T cell exhaustion impact HCC survival.
Area Of Science
- Immunology
- Oncology
- Cancer Research
Background
- Hepatocellular carcinoma (HCC) progression is influenced by tumor immune microenvironment dynamics, including immune escape and T cell function.
- Understanding the roles of programmed cell death ligand 1 (PD-L1) and CD39 in HCC is crucial for prognostic insights.
Purpose Of The Study
- To investigate the prognostic significance of PD-L1 expression in tumor cells and CD39 expression in tumor-infiltrating CD8+ T cells in HCC patients.
- To explore the combined impact of these markers on overall survival in hepatocellular carcinoma.
Main Methods
- Multiplex immunofluorescence assays were used to quantify PD-L1 and CD39 expression in 91 HCC patient samples.
- Kaplan-Meier analyses were employed to assess the relationship between marker expression levels and patient prognosis.
Main Results
- Individual upregulation of PD-L1 or CD39 did not significantly alter HCC patient prognosis.
- Simultaneous upregulation of PD-L1 in tumor cells and CD39 in CD8+ T cells was significantly associated with reduced overall survival.
- This combined expression pattern suggests a link between tumor immune escape and T cell exhaustion in HCC.
Conclusions
- The interplay between tumor cell immune escape (PD-L1) and T cell functional status (CD39) significantly impacts HCC prognosis.
- Combined PD-L1 and CD39 upregulation may serve as a potential prognostic biomarker for hepatocellular carcinoma.
- This finding highlights the importance of evaluating both tumor and immune cell markers for predicting HCC outcomes.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
